The conformation of neurotensin bound to its G protein-coupled receptor

Abstract

G protein-coupled receptors (GPCRs) mediate the perception of smell, light, taste, and pain. They are involved in signal recognition and cell communication and are some of the most important targets for drug development. Because currently no direct structural information on high-affinity ligands bound to GPCRs is available, rational drug design is limited to computational prediction combined with mutagenesis experiments. Here, we present the conformation of a high-affinity peptide agonist (neurotensin, NT) bound to its GPCR NTS-1, determined by direct structural methods. Functional receptors were expressed in Escherichia coli, purified in milligram amounts by using optimized procedures, and subsequently reconstituted into lipid vesicles. Solid-state NMR experiments were tailored to allow for the unequivocal detection of microgram quantities of 13 C, 15 N-labeled NT(8 -13) in complex with functional NTS-1. The NMR data are consistent with a disordered state of the ligand in the absence of receptor. Upon receptor binding, the peptide undergoes a linear rearrangement, adopting a ␤-strand conformation. Our results provide a viable structural template for further pharmacological investigations.G protein-coupled receptors (GPCRs) are integral membrane proteins involved in a number of important physiological processes, including sensory transduction, mediation of hormonal activity, and cell-to-cell communication (for reviews, see refs. 1 and 2). More than 1,000 different GPCRs have been identified, and many of them have been implicated as major therapeutic routes to the treatment of human diseases (3). Despite the striking clinical relevance of GPCRs, only one high-resolution structure (rhodopsin) is available (4, 5). The diversity among endogenous GPCR ligands is exceptional. Small molecule ligands such as biogenic amines have been proposed to bind within the hydrophobic core of their respective receptors. In contrast, mutational mapping of ligand-binding sites in peptide receptors indicates that extracellular domains are also involved in ligand recognition (2). To date, direct structural information regarding ligand binding and GPCR activation is very limited (6). Targeted drug design is restricted to computational methods and other ligand design approaches to find and optimize lead compounds (7). The precise knowledge of receptor-bound ligand structures would substantially aid the development of tailor-made medicines.Neurotensin (NT) is a 13-aa peptide (8) that is involved in a variety of neuromodulatory functions in the central and peripheral nervous system (9). NT binds to its GPCRs, NT type I receptor (NTS-1) and NTS-2 (10 -13). The levocabastineinsensitive NTS-1 (10-12) interacts with the agonist NT with high (i.e., subnanomolar) affinity. Similar observations were made for the N-terminally truncated form of rat NTS-1 when expressed as a maltose-binding protein (MBP) fusion in Escherichia coli (14, 15) and purified in the presence of detergents (14, 16). Notably, not only the full-length peptide, but also the C-...

Interaction of Monomeric Interleukin-8 with CXCR1 Mapped by Proton-Detected Fast MAS Solid-State NMR

“…There are several examples where solid-state NMR methods have been used to characterize the structures of ligands bound to GPCRs (41)(42)(43)(44) as well as GPCRs themselves. Most prior studies of membrane proteins or their ligands have involved the direct detection of signals from labeled 13 C or 15 N sites; this continues to be a fruitful approach and we applied it in our earlier studies of CXCR1 (23,33,45).…”

Expression of membrane proteins from Mycobacterium tuberculosis in Escherichia coli as fusions with maltose binding protein

“…During the last decade increasing efforts to express prokaryotic and eukaryotic membrane proteins have resulted in significant advancements for the expression of several bacterial transporter proteins [3][4][5][6][7][8][9], outer membrane proteins of bacteria [10], membrane protein complexes [11][12][13] and a few eukaryotic G-protein coupled receptors [14][15][16][17][18][19][20][21]. With others we have successfully expressed more than 70 membrane proteins from Mycobacterium tuberculosis in Escherichia coli using a His-tag [22].…”

Sensitivity Enhancement in Two‐Dimensional Solid‐State NMR Spectroscopy by Transverse Mixing

“…Even at the highest available magnetic fields and with the most advanced solid-state NMR equipment and techniques, approximately 100 nmol of isotopically enriched material and many hours or several days of signal averaging are typically required for simple two-dimensional (2D) spectroscopy of peptides and proteins in a noncrystalline solid form with uniform 15 N and 13 C labeling of selected amino acids or segments of the amino acid sequence. [1,2] Significantly more material is generally required for higher-dimensional spectroscopy or for solid-state NMR measurements that yield quantitative constraints on interatomic distances or torsion angles. Sample quantities of this magnitude are not currently available for many potentially interesting targets for solid-state NMR, such as most membrane-bound receptor proteins.…”